644 related articles for article (PubMed ID: 8394670)
1. Expression of p53 protein related to the presence of human papillomavirus (HPV) DNA in genital carcinomas and precancer lesions.
Tervahauta AI; Syrjänen SM; Väyrynen M; Saastamoinen J; Syrjänen KJ
Anticancer Res; 1993; 13(4):1107-11. PubMed ID: 8394670
[TBL] [Abstract][Full Text] [Related]
2. Expression of p53 protein related to the presence of human papillomavirus infection in precancer lesions of the larynx.
Fouret P; Dabit D; Sibony M; Alili D; Commo F; Saint-Guily JL; Callard P
Am J Pathol; 1995 Mar; 146(3):599-604. PubMed ID: 7887442
[TBL] [Abstract][Full Text] [Related]
3. Human papillomavirus, Epstein-Barr virus and p53 mutation in vulvar intraepithelial neoplasia.
Almeida G; do Val I; Gondim C; Lima R; Takiya C; Carvalho G
J Reprod Med; 2004 Oct; 49(10):796-9. PubMed ID: 15568402
[TBL] [Abstract][Full Text] [Related]
4. p16 overexpression identifies HPV-positive vulvar squamous cell carcinomas.
Santos M; Landolfi S; Olivella A; Lloveras B; Klaustermeier J; Suárez H; Alòs L; Puig-Tintoré LM; Campo E; Ordi J
Am J Surg Pathol; 2006 Nov; 30(11):1347-56. PubMed ID: 17063073
[TBL] [Abstract][Full Text] [Related]
5. Genetic alterations of the TP53 gene, p53 protein expression and HPV infection in primary cervical carcinomas.
Helland A; Holm R; Kristensen G; Kaern J; Karlsen F; Trope C; Nesland JM; Børresen AL
J Pathol; 1993 Oct; 171(2):105-14. PubMed ID: 8283348
[TBL] [Abstract][Full Text] [Related]
6. The status of human papillomavirus and tumor suppressor genes p53 and p16 in carcinomas of uterine cervix from India.
Munirajan AK; Kannan K; Bhuvarahamurthy V; Ishida I; Fujinaga K; Tsuchida N; Shanmugam G
Gynecol Oncol; 1998 Jun; 69(3):205-9. PubMed ID: 9648588
[TBL] [Abstract][Full Text] [Related]
7. [Ha-ras and p53 gene mutations scanned by PCR-SSCP in premalignant and malignant lesions of the uterine cervix associated with human papillomavirus].
Alonio LV; Dalbert D; Picconi MA; Cervantes Vazquez G; García Carrancá A; Distefano AL; Mural J; Bartt O; Bazan G; Teyssie AR
Medicina (B Aires); 2000; 60(6):895-901. PubMed ID: 11436698
[TBL] [Abstract][Full Text] [Related]
8. Human papillomavirus detection and p53 expression in clear-cell adenocarcinoma of the vagina and cervix.
Waggoner SE; Anderson SM; Van Eyck S; Fuller J; Luce MC; Herbst AL
Obstet Gynecol; 1994 Sep; 84(3):404-8. PubMed ID: 8058239
[TBL] [Abstract][Full Text] [Related]
9. Presence of p53 mutation in human cervical carcinomas associated with HPV-33 infection.
Lo KW; Mok CH; Chung G; Huang DP; Wong F; Chan M; Lee JC; Tsao SW
Anticancer Res; 1992; 12(6B):1989-94. PubMed ID: 1363512
[TBL] [Abstract][Full Text] [Related]
10. New human papillomavirus sequences in female genital tumors from Japanese patients.
Saito J; Yutsudo M; Inoue M; Ueda G; Tanizawa O; Hakura A
Jpn J Cancer Res; 1987 Oct; 78(10):1081-7. PubMed ID: 2824417
[TBL] [Abstract][Full Text] [Related]
11. Second genital primary squamous neoplasms in vulvar carcinoma: viral and histopathologic correlates.
Mitchell MF; Prasad CJ; Silva EG; Rutledge FN; McArthur MC; Crum CP
Obstet Gynecol; 1993 Jan; 81(1):13-8. PubMed ID: 8380102
[TBL] [Abstract][Full Text] [Related]
12. Physical status and expression of HPV genes in cervical cancers.
Park JS; Hwang ES; Park SN; Ahn HK; Um SJ; Kim CJ; Kim SJ; Namkoong SE
Gynecol Oncol; 1997 Apr; 65(1):121-9. PubMed ID: 9103401
[TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus infections in vulvar precancerous lesions and cancer.
Costa S; Syrjänen S; Vendra C; Chang F; Guida G; Hippeläinen M; Terzano P; Tervahauta A; Yliskoski M; Syrjänen K
J Reprod Med; 1995 Apr; 40(4):291-8. PubMed ID: 7623359
[TBL] [Abstract][Full Text] [Related]
14. The distribution of low and high-risk HPV types in vulvar and vaginal intraepithelial neoplasia (VIN and VaIN).
Srodon M; Stoler MH; Baber GB; Kurman RJ
Am J Surg Pathol; 2006 Dec; 30(12):1513-8. PubMed ID: 17122506
[TBL] [Abstract][Full Text] [Related]
15. Correlation between human papillomavirus positivity and p53 gene overexpression in adenocarcinoma of the uterine cervix.
Uchiyama M; Iwasaka T; Matsuo N; Hachisuga T; Mori M; Sugimori H
Gynecol Oncol; 1997 Apr; 65(1):23-9. PubMed ID: 9103386
[TBL] [Abstract][Full Text] [Related]
16. Cervical squamous dysplasias and carcinomas with immunodetectable p53 frequently contain HPV.
Mittal KR; Lin O; Chan W; Goswami S; Demopoulos RI
Gynecol Oncol; 1995 Sep; 58(3):289-94. PubMed ID: 7672694
[TBL] [Abstract][Full Text] [Related]
17. p16 expression in the female genital tract and its value in diagnosis.
O'Neill CJ; McCluggage WG
Adv Anat Pathol; 2006 Jan; 13(1):8-15. PubMed ID: 16462152
[TBL] [Abstract][Full Text] [Related]
18. The presence of high-risk HPV combined with specific p53 and p16INK4a expression patterns points to high-risk HPV as the main causative agent for adenocarcinoma in situ and adenocarcinoma of the cervix.
Zielinski GD; Snijders PJ; Rozendaal L; Daalmeijer NF; Risse EK; Voorhorst FJ; Jiwa NM; van der Linden HC; de Schipper FA; Runsink AP; Meijer CJ
J Pathol; 2003 Dec; 201(4):535-43. PubMed ID: 14648656
[TBL] [Abstract][Full Text] [Related]
19. P16 and Ki67 immunostaining is a useful adjunct in the assessment of biopsies for HPV-associated anal intraepithelial neoplasia.
Walts AE; Lechago J; Bose S
Am J Surg Pathol; 2006 Jul; 30(7):795-801. PubMed ID: 16819320
[TBL] [Abstract][Full Text] [Related]
20. The etiologic role of HPV in vulvar squamous cell carcinoma fine tuned.
van de Nieuwenhof HP; van Kempen LC; de Hullu JA; Bekkers RL; Bulten J; Melchers WJ; Massuger LF
Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):2061-7. PubMed ID: 19567503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
